Hypertension – IV

  • Cleviprex 2021 report

    Cleviprex 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Copiktra 2020 report

    Copiktra 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Cleviprex 2019 report

    Cleviprex 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Cardene IV 2018 report

    Cardene IV 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 34 Pages The 5 Key Questions Addressed by this...

  • Cleviprex 2018 report

    Cleviprex 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 34 Pages The 5 Key Questions Addressed by this Report:...

  • Cardene IV 2017 report

    Cardene IV 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 32 Pages The 5 Key Questions Addressed by this...

  • Cleviprex 2017 report

    Cleviprex 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 34 Pages The 5 Key Questions Addressed by this Report:...

  • Cardene IV 2016 report

    Cardene IV 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 •  32| Pages The 5 Key Questions Addressed by...

  • Cleviprex 2016 report

    Cleviprex 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Cardene IV 2015 report

    Cardene IV 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 29 Pages The 5 Key Questions Addressed by...

  • Cleviprex 2015 report

    Cleviprex 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 35 Pages The 5 Key Questions Addressed by this...

  • Cardene IV 2014 report

    Cardene IV 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 32 Pages The 5 Key Questions Addressed by...